Fortuitous vasculitis

Renal Failure

Volumn 34, Issue 3, 2012, Pages 378-382

  Sharma, Hema ^a,b   Keshavan, Ashvini ^a   Little, Mark Alan ^a   Cross, Jennifer ^a   Lipman, Marc C ^a   Talukdar, Sabrina ^a   Hopkins, Susan ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

ANCA negative vasculitis; Cardiac device; Infective endocarditis; Mycobacterium fortuitum; Pauci immune necrotizing crescentic glomerulonephritis

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; MEROPENEM; NEUTROPHIL CYTOPLASMIC ANTIBODY; OSELTAMIVIR; PREDNISOLONE; TEICOPLANIN; VORICONAZOLE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ASPERGILLOSIS; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BONE MARROW CULTURE; CONGESTIVE CARDIOMYOPATHY; DEVICE INFECTION; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FORTUITOUS VASCULITIS; GLOMERULONEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM FORTUITUM; PANCYTOPENIA; PRIORITY JOURNAL; SEPSIS; SMALL VESSEL VASCULITIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULITIS; VISUAL HALLUCINATION;

ADULT; CARDIOMYOPATHY, DILATED; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FATAL OUTCOME; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PACEMAKER, ARTIFICIAL; VASCULITIS;

EID: 84857566633     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.647337     Document Type: Article

References (19)

1. Albouaini K, Mudawi J, Pyatt J, Wright D. Implantable cardioverter defibrillator: What a hospital practitioner needs to know. Eur J Intern Med. 2009;20(6):591-597.
2. Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverterdefibrillators: Results of a large prospective study. Circulation. 2007;116(12):1349-1355. (Pubitemid 47417560)
3. Howie AJ, Ferreira MA, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant. 2001;16(6):1163-1169. (Pubitemid 32547370)
4. Majumdar A, Chowdhary S, Ferreira MAS, et al. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant. 2000;15(11):1782-1787.
5. Raoult D, Casalta JP, Richet H, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43(10):5238-5242. (Pubitemid 41484031)
6. Eisenberger U, Fakhouri F, Vanhille P, et al. ANCA-negative pauci-immune renal vasculitis: Histology and outcome. Nephrol Dial Transplant. 2005;20:1392-1399. (Pubitemid 41430612)
7. Chen M, Feng Y, Wang S-X, et al. Antineutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599-605. (Pubitemid 46193325)
8. Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14(10):1088-1096.
9. Agarwal A, Clements J, Sedmak DD, et al. Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol. 1997;8(12): 1971-1976. (Pubitemid 28185457)
10. Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis: Report of 44 cases and review of the literature. Medicine. 1994;73:299-305.
11. Task Force on the Prevention, Diagnosis and Treatment of Infective Endocarditis of the European Society of Cardiology; European Society of Clinical Microbiology and Infectious Diseases; International Society of Chemotherapy for Infection and Cancer, Habib G, Hoen B, et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 009): The Task Force on the Prevention, Diagnosis and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19): 2369-2413.
12. Rundström H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis. 2004;36(9):674-679.
13. Sohail MR, Uslan DZ, Khan AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46-53.
14. Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiological cardiac devices. Ann Intern Med. 2000;133:604-608.
15. Al Soub H, Al Maslamani M, Al Khuwaiter J, El Deeb Y, Abu Khattab M. Myocardial abscess and bacteremia complicating Mycobacterium fortuitum pacemaker infection: Case report and review of the literature. Pediatr Infect Dis J. 2009;28(11): 1032-1034.
16. Hemmersbach-Miller M, Cárdenes-Santana MA, Conde- Martel A, Bolaños-Guerra JA, Campos-Herrero MI. Cardiac device infections due to Mycobacterium fortuitum. Can J Infect Dis Med Microbiol. 2005;16(3):183-185. (Pubitemid 41113434)
17. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: Diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367-416.
18. Chen HH, Hsiao CH, Chiu HC. Successive development of cutaneous polyarteritis nodosa, leucocytoclastic vasculitis and Sweet's syndrome in a patient with cervical lymphadenitis caused by Mycobacterium fortuitum. Br J Dermatol. 2004;151(5):1096-1100.
19. Al Shaalan M, Law BJ, Israels SJ, Pianosi P, Lacson AG, Higgins R. Mycobacterium fortuitum interstitial pneumonia with vasculitis in a child with Wilms' tumor. Pediatr Infect Dis J. 1997;16(10):996-1000. (Pubitemid 27452320)